Somalia vs Sur: Hepatitis B surface antigen (HBsAg) prevalence
Somalia
4.0%
in 2024
Sur
0.2%
in 2024
Somalia rank
2nd
Sur rank
1st
Hepatitis B surface antigen (HBsAg) prevalence over time
- Somalia
- Sur
How they compare
Somalia currently reports 4.0% against 0.2% in Sur, a difference of 3.8%.
That makes Somalia's figure about 20.0 times Sur's.
Across all 10 years both countries report, Somalia has been ahead every year.
Somalia ranks 2nd and Sur ranks 1st of 194 countries.
Somalia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Somalia | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 6.4% | 0.2% | 6.2% | Somalia |
| 2020s | 4.4% | 0.2% | 4.2% | Somalia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Somalia or Sur?
- Somalia, at 4.0% against 0.2% in Sur as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Somalia and Sur?
- 3.8%, with Somalia ahead.
- How many years of comparable data are there for Somalia and Sur?
- 10 years are reported by both, from 2015 to 2024.
- How do Somalia and Sur rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Somalia ranks 2nd and Sur ranks 1st of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.